INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 179 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $138,100 | -85.0% | 10,000 | -82.3% | 0.00% | -80.0% |
| Q4 2021 | $920,385 | +9.7% | 56,500 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $839,025 | -25.2% | 56,500 | +24.4% | 0.01% | -25.0% |
| Q4 2020 | $1,121,528 | -40.1% | 45,406 | +0.6% | 0.01% | -61.9% |
| Q3 2020 | $1,872,000 | +28.8% | 45,155 | +48.9% | 0.02% | +23.5% |
| Q2 2020 | $1,453,000 | -21.2% | 30,322 | +3.5% | 0.02% | -15.0% |
| Q1 2020 | $1,845,000 | -93.3% | 29,303 | -86.8% | 0.02% | -90.6% |
| Q4 2019 | $27,468,000 | +206.5% | 221,658 | +64.1% | 0.21% | +204.3% |
| Q3 2019 | $8,961,000 | +69.0% | 135,050 | +102.7% | 0.07% | +79.5% |
| Q2 2019 | $5,301,000 | +91.0% | 66,620 | +168.5% | 0.04% | +69.6% |
| Q1 2019 | $2,776,000 | -5.4% | 24,809 | -14.7% | 0.02% | -4.2% |
| Q4 2018 | $2,933,000 | -62.4% | 29,095 | -78.2% | 0.02% | -33.3% |
| Q4 2017 | $7,806,000 | -64.6% | 133,613 | -64.8% | 0.04% | -75.2% |
| Q3 2017 | $22,053,000 | +9364.8% | 379,959 | +19607.4% | 0.14% | +7150.0% |
| Q2 2017 | $233,000 | -57.5% | 1,928 | -61.8% | 0.00% | 0.0% |
| Q4 2016 | $548,000 | -80.8% | 5,043 | -70.8% | 0.00% | -85.7% |
| Q3 2016 | $2,847,000 | -45.4% | 17,298 | -57.4% | 0.01% | -53.3% |
| Q1 2016 | $5,219,000 | +1248.6% | 40,623 | +1467.2% | 0.03% | +1400.0% |
| Q4 2015 | $387,000 | +47.1% | 2,592 | +63.7% | 0.00% | 0.0% |
| Q3 2015 | $263,000 | +26200.0% | 1,583 | +39475.0% | 0.00% | – |
| Q2 2015 | $1,000 | -100.0% | 4 | -100.0% | 0.00% | -100.0% |
| Q4 2014 | $3,822,000 | -42.2% | 24,500 | -12.4% | 0.02% | -48.9% |
| Q3 2014 | $6,618,000 | +27.4% | 27,960 | +27.4% | 0.04% | +2.3% |
| Q2 2014 | $5,193,000 | – | 21,945 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |